Bacterial Infections  >>  gepotidacin (GSK2140944)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gepotidacin (GSK2140944) / GSK
NCT01934205: To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

Completed
1
22
US
GSK2140944 (Single dose), GSK2140944 (Multiple dose)
GlaxoSmithKline
Infections, Bacterial
12/13
12/13
NCT02045849: Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Completed
1
46
US
GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule
GlaxoSmithKline
Infections, Bacterial
08/14
08/14

Download Options